{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:34:24Z","timestamp":1792978464081,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI21\/01935"],"award-info":[{"award-number":["PI21\/01935"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI18\/01659"],"award-info":[{"award-number":["PI18\/01659"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012619","name":"Biomedical Research Network Centre of Fragility and Healthy Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.biopha.2025.118279","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T07:33:18Z","timestamp":1750231998000},"page":"118279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Antidiabetic sitagliptin influences tissue regeneration by affecting progenitor cells"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6934-3958","authenticated-orcid":false,"given":"B\u00e1rbara","family":"Torrecillas-Baena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1107-1547","authenticated-orcid":false,"given":"Victoria","family":"Pulido-Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Quesada-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Moreno-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aura D.","family":"Herrera-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Dorado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"G\u00e1lvez-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0921-2670","authenticated-orcid":false,"given":"Marta","family":"Camacho-Cardenosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8520-8278","authenticated-orcid":false,"given":"Antonio","family":"Casado-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118279_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/medicina57101072","article-title":"Diabetic wound-healing science","volume":"57","author":"Burgess","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.biopha.2025.118279_bib2","first-page":"2702","article-title":"Combination of biomaterials and extracellular vesicles from mesenchymal stem-cells: new therapeutic strategies for skin-wound healing","volume":"13","author":"Pulido-Escribano","year":"2023","journal-title":"Appl. Sci. 2023"},{"key":"10.1016\/j.biopha.2025.118279_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11914-015-0260-5","article-title":"Diabetes, diabetic complications, and fracture risk","volume":"13","author":"Oei","year":"2015","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.biopha.2025.118279_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118279_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00592-018-1101-7","article-title":"Insulin resistance and bone: a biological partnership","volume":"55","author":"Conte","year":"2018","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.biopha.2025.118279_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2018.05.019","article-title":"Defining osteoblast and adipocyte lineages in the bone marrow","volume":"118","author":"Pierce","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2025.118279_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones","volume":"3","author":"Drucker","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2025.118279_bib8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41574-020-0399-8","article-title":"Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus","volume":"16","author":"Deacon","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118279_bib9","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1210\/er.2014-1035","article-title":"Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors","volume":"35","author":"Mulvihill","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.biopha.2025.118279_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12015-021-10285-w","article-title":"Influence of dipeptidyl peptidase-4 (DPP4) on mesenchymal stem-cell (MSC) Biology: implications for regenerative medicine \u2013 review","volume":"18","author":"Torrecillas-Baena","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.biopha.2025.118279_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/wound.2012.0398","article-title":"The role of endothelial progenitor cells in postnatal vasculogenesis: implications for therapeutic neovascularization and wound healing","volume":"2","author":"Balaji","year":"2013","journal-title":"Adv. Wound Care"},{"key":"10.1016\/j.biopha.2025.118279_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pharmthera.2016.07.009","article-title":"Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: potential impact of dipeptidyl peptidase-4 inhibitors","volume":"167","author":"Anderluh","year":"2016","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2025.118279_bib13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jcyt.2019.09.002","article-title":"Endothelial progenitor cell therapy for chronic wound tissue regeneration","volume":"21","author":"Kaushik","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.biopha.2025.118279_bib14","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1089\/ten.tea.2018.0265","article-title":"CXCR4 antagonism to treat delayed fracture healing","volume":"25","author":"Meeson","year":"2019","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.biopha.2025.118279_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.dsx.2015.04.006","article-title":"Wound healing effects of dipeptidyl peptidase-4 inhibitors: an emerging concept in management of diabetic foot ulcer-A review","volume":"10","author":"Saboo","year":"2016","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.biopha.2025.118279_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8874272","article-title":"DPP4 activities are associated with osteopenia\/osteoporosis and fracture risk in newly diagnosed Type 2 diabetes","volume":"2020","author":"Qiu","year":"2020","journal-title":"Int J. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118279_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109796","article-title":"Anagliptin stimulates osteoblastic cell differentiation and mineralization","volume":"129","author":"Dong","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118279_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2014.01.028","article-title":"Saxagliptin affects long-bone microarchitecture and decreases the osteogenic potential of bone marrow stromal cells","volume":"727","author":"Sbaraglini","year":"2014","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118279_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12144632","article-title":"Non-specific inhibition of dipeptidyl peptidases 8\/9 by dipeptidyl peptidase 4 inhibitors negatively affects mesenchymal stem cell differentiation","volume":"12","author":"Torrecillas-Baena","year":"2023","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.biopha.2025.118279_bib20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/14653240802192644","article-title":"Cryopreserved human bone marrow mononuclear cells as a source of mesenchymal stromal cells: application in osteoporosis research","volume":"10","author":"Casado-D\u00edaz","year":"2008","journal-title":"Cytotherapy"},{"key":"10.1016\/j.biopha.2025.118279_bib21","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3906\/sag-2007-234","article-title":"Effects of sitagliptin on \u00df-adrenoceptor mediated relaxation in streptozotocin-diabetic rat aorta","volume":"51","author":"M\u00fcderr\u0131so\u011flu","year":"2021","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.biopha.2025.118279_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2019.103238","article-title":"A comparative study of the role of crocin and sitagliptin in attenuation of STZ-induced diabetes mellitus and the associated inflammatory and apoptotic changes in pancreatic \u03b2-islets","volume":"72","author":"Samaha","year":"2019","journal-title":"Environ. Toxicol. Pharm."},{"key":"10.1016\/j.biopha.2025.118279_bib23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.archoralbio.2019.04.018","article-title":"Sitagliptin\u2019s effects on bone tissue and osseointegration in diabetic rats","volume":"102","author":"Bautista","year":"2019","journal-title":"Arch. Oral. Biol."},{"key":"10.1016\/j.biopha.2025.118279_bib24","article-title":"Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat)","volume":"2010","author":"Reis","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2025.118279_bib25","unstructured":"Drug Approval Package: Januvia (Sitagliptin Phosphate) NDA #021995, (n.d.). \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2006\/021995s000TOC.cfm\u3009 (Accessed May 22, 2025)."},{"key":"10.1016\/j.biopha.2025.118279_bib26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1089\/wound.2021.0161","article-title":"Inflammation in wound healing and pathological scarring","volume":"12","author":"Hong","year":"2023","journal-title":"Adv. Wound Care"},{"key":"10.1016\/j.biopha.2025.118279_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.peptides.2017.10.011","article-title":"Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes","volume":"100","author":"Deacon","year":"2018","journal-title":"Pept. (N. Y. )"},{"key":"10.1016\/j.biopha.2025.118279_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020185","article-title":"Involvement of CXCR4 in normal and abnormal development","volume":"8","author":"Kawaguchi","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118279_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-023-03537-8","article-title":"Endothelial progenitor cells as biomarkers of diabetes-related cardiovascular complications","volume":"14","author":"Ben\u00edtez-Camacho","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.biopha.2025.118279_bib30","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2337\/dc10-0187","article-title":"The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha","volume":"33","author":"Fadini","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2025.118279_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1089\/ten.teb.2013.0511","article-title":"Clinical impact of circulating CD34-positive cells on bone regeneration and healing","volume":"20","author":"Kuroda","year":"2014","journal-title":"Tissue Eng. Part B Rev."},{"key":"10.1016\/j.biopha.2025.118279_bib32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/ATVBAHA.110.216879","article-title":"Human CD34+\/KDR+ cells are generated from circulating CD34+ cells after immobilization on activated platelets","volume":"31","author":"De Boer","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2025.118279_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jcmm.13296","article-title":"Sitagliptin-mediated preservation of endothelial progenitor cell function via augmenting autophagy enhances ischaemic angiogenesis in diabetes","volume":"22","author":"Dai","year":"2018","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2025.118279_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00823","article-title":"Sitagliptin stimulates endothelial progenitor cells to induce endothelialization in aneurysm necks through the SDF-1\/CXCR4\/NRF2 signaling pathway","volume":"10","author":"Yu","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118279_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082639","article-title":"Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through VEGF-A\/VEGFR-2 signaling pathway","volume":"8","author":"Samikannu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118279_bib36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2298\/ABS150506143L","article-title":"DPP4 inhibitors promote biological functions of human endothelial progenitor cells by targeting the SDF-1\/CXCR4 signaling pathway","volume":"68","author":"Liu","year":"2016","journal-title":"Arch. Biol. Sci."},{"key":"10.1016\/j.biopha.2025.118279_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1124\/jpet.111.191098","article-title":"The dipeptidyl peptidase-4 inhibitor linagliptin attenuates inflammation and accelerates epithelialization in wounds of diabetic ob\/ob mice","volume":"342","author":"Sch\u00fcrmann","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2025.118279_bib38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.diabres.2017.02.010","article-title":"Sitagliptin but not alpha glucosidase inhibitor reduced the serum soluble CD163, a marker for activated macrophage, in individuals with type 2 diabetes mellitus","volume":"126","author":"Hattori","year":"2017","journal-title":"Diabetes Res. Clin. Pr."},{"key":"10.1016\/j.biopha.2025.118279_bib39","article-title":"Sitagliptin phosphate ameliorates chronic inflammation in diabetes mellitus via modulating macrophage polarization","volume":"16","author":"Hu","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2025.118279_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-021-00625-7","article-title":"Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NF\u03baB pathway","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biopha.2025.118279_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11071418","article-title":"Antioxidant effects of DPP-4 inhibitors in early stages of experimental diabetic retinopathy","volume":"11","author":"Ramos","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2025.118279_bib42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11154-015-9310-7","article-title":"Angiogenesis in diabetes and obesity","volume":"16","author":"Cheng","year":"2015","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.biopha.2025.118279_bib43","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jcyt.2013.05.005","article-title":"Sitagliptin therapy enhances the number of circulating angiogenic cells and angiogenesis\u2014evaluations in vitro and in the rat critical limb ischemia model","volume":"15","author":"Chua","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.biopha.2025.118279_bib44","first-page":"359","article-title":"Role of chemokines in angiogenesis: CXCL12\/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses","volume":"10","author":"Salcedo","year":"2003","journal-title":"Microcirculation"},{"key":"10.1016\/j.biopha.2025.118279_bib45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biomaterials.2018.06.026","article-title":"Bone marrow mesenchymal stem cells: Aging and tissue engineering applications to enhance bone healing","volume":"203","author":"Lin","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2025.118279_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.peptides.2014.05.006","article-title":"Soluble DPP4 originates in part from bone marrow cells and not from the kidney","volume":"57","author":"Wang","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2025.118279_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep23074","article-title":"Metabolic role of dipeptidyl peptidase 4 (DPP4) in primary human (pre)adipocytes","volume":"6","author":"Zille\u00dfen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118279_bib48","article-title":"Identification of a mesenchymal progenitor cell hierarchy in adipose tissue","volume":"364","author":"Merrick","year":"2019","journal-title":"Science (1979)"},{"key":"10.1016\/j.biopha.2025.118279_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bone.2016.08.009","article-title":"Boning up on DPP4, DPP4 substrates, and DPP4-adipokine interactions: logical reasoning and known facts about bone related effects of DPP4 inhibitors","volume":"92","author":"Glorie","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2025.118279_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2013-02-487470","article-title":"Implications of DPP4 modification of proteins that regulate stem\/progenitor and more mature cell types","volume":"122","author":"Ou","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118279_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5765478","article-title":"Effects of Type 2 diabetic serum on proliferation and osteogenic differentiation of mesenchymal stem cells","volume":"2018","author":"Deng","year":"2018","journal-title":"J. Diabetes Res"},{"key":"10.1016\/j.biopha.2025.118279_bib52","doi-asserted-by":"crossref","DOI":"10.1007\/s40265-024-02078-5","article-title":"Bone fragility in diabetes and its management: a narrative review","author":"Leungsuwan","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2025.118279_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/1749-799X-5-37","article-title":"Transcriptional regulation of bone formation by the osteoblast-specific transcription factor Osx","volume":"5","author":"Zhang","year":"2010","journal-title":"J. Orthop. Surg. Res"},{"key":"10.1016\/j.biopha.2025.118279_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.diff.2024.100757","article-title":"Type 1 collagen: synthesis, structure and key functions in bone mineralization","volume":"136","author":"Selvaraj","year":"2024","journal-title":"Differentiation"},{"key":"10.1016\/j.biopha.2025.118279_bib55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cytogfr.2019.09.001","article-title":"Collagen and non-collagenous proteins molecular crosstalk in the pathophysiology of osteoporosis","volume":"49","author":"Licini","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.biopha.2025.118279_bib56","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.922644","article-title":"Sitagliptin inhibits extracellular matrix accumulation and proliferation in lung fibroblasts","volume":"26","author":"Liu","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.biopha.2025.118279_bib57","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.928933","article-title":"Functional dissection of cd26 and its pharmacological inhibition by sitagliptin during skin wound healing","volume":"27","author":"Jiang","year":"2021","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.biopha.2025.118279_bib58","article-title":"Sitagliptin ameliorates busulfan-induced pulmonary and testicular injury in rats through antioxidant, anti-inflammatory, antifibrotic, and antiapoptotic effects","volume":"13","author":"Ali","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118279_bib59","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.apjtm.2016.07.014","article-title":"Changes of adipocytokine expression after diabetic rats received sitagliptin and the molecular mechanism","volume":"9","author":"Wu","year":"2016","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.biopha.2025.118279_bib60","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1194\/jlr.M059469","article-title":"Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus","volume":"56","author":"Furuhashi","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2025.118279_bib61","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1194\/jlr.S091793","article-title":"Adipokine FABP4 integrates energy stores and counterregulatory metabolic responses","volume":"60","author":"Prentice","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2025.118279_bib62","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3390\/ijms24021032","article-title":"FABP4 controls fat mass expandability (Adipocyte Size and Number) through inhibition of CD36\/SR-B2 signalling","volume":"24","author":"Berger","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118279_bib63","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00223-018-0507-0","article-title":"Sitagliptin alters bone composition in high-fat-fed mice","volume":"104","author":"Mansur","year":"2019","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.biopha.2025.118279_bib64","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.21037\/qims.2020.01.11","article-title":"Fat and bone: the multiperspective analysis of a close relationship","volume":"10","author":"G\u00f3mez","year":"2020","journal-title":"Quant. Imaging Med. Surg."},{"key":"10.1016\/j.biopha.2025.118279_bib65","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00223-018-0507-0","article-title":"Sitagliptin alters bone composition in high-fat-fed mice","volume":"104","author":"Mansur","year":"2019","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.biopha.2025.118279_bib66","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1152\/ajpendo.00217.2014","article-title":"DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats","volume":"307","author":"Glorie","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118279_bib67","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5603\/EP.a2021.0031","article-title":"Evaluation of the risk of fracture in type 2 diabetes mellitus patients with incretins: an updated meta-analysis","volume":"72","author":"Kong","year":"2021","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.biopha.2025.118279_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00677","article-title":"Sitagliptin and fractures in Type 2 diabetes: a nationwide population-based propensity-matching study","volume":"9","author":"Lin","year":"2018","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2025.118279_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.735824","article-title":"Effects of anti-diabetic drugs on fracture risk: a systematic review and network meta-analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Endocrinol."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2026.119657","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000}},{"DOI":"10.1016\/j.biopha.2026.119657","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225004731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225004731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:09:40Z","timestamp":1786075780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225004731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":69,"alternative-id":["S0753332225004731"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118279","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidiabetic sitagliptin influences tissue regeneration by affecting progenitor cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118279"}}